HLA class I in acute promyelocytic leukemia (APL): Possible correlation with clinical outcome

Leukemia

Volumn 14, Issue 3, 2000, Pages 393-398

  Bolognesi, E ^a,e   Cimino, G ^b   Diverio, D ^b   Rapanotti, M C ^b   D'Alfonso, S ^a   Fleischhauer, K ^c   Migliaretti, G ^a,d   Momigliano Richiardi, P ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d CPO Piemonte   (Italy)

^e Amedeo Avogadro University   (Italy)

Author keywords

APL; HLA; Relapse

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; IDARUBICIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; BINDING AFFINITY; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE FREQUENCY; GENE FUSION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELAPSE; TREATMENT OUTCOME;

EID: 0034054655     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401691     Document Type: Article

References (28)

1. Hester JP, Rossen R, Trujillo J, McCredie KB, Freireich EJ. Frequency of HLA antigens in chronic myelocitic leukemia. S Med J 1977; 70: 691-693.
2. Navarrete C, Alonso A, Awad J, McCloskey D, Ganesan TS, Amess J, Lister TA, Festenstein H. HLA class I and class II antigens association in acute leukemias. J Immunogenet 1986; 13: 77-84.
3. Annino L, Ferrari A, Laurenti L, Perrone MP, Romani C, Pacchiarotti A, Girelli G, Mandelli F. HLA typing in hairy cell leukemia. Leuk Lymphoma 1994; 14: 63-65.
4. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P. PMLRAR homodimers: distinct DNA properties and heterodimeric interactions with RXR. EMBO J 1993; 12: 3171-3182.
5. Pandolfi PP, Alcalay M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gauh MP, Chambon P, Pelicci PG. Genomic variability and alternative splicings generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemias. EMBO J 1992; 11: 1397-1407.
6. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 1996; 87: 3587-3592.
7. Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti E, Butler R, Tanigaki N, Tosi R. Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 1996; 10: 639-699.
8. Lecchi M, Lovisone E, Genetta C, Peruccio D, Resegotti L, Richiardi P. Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Leukemia Res 1989; 13: 221-226.
9. Jinnai I. In vitro growth response to G-CSF and GM-CSF by bone marrow cells of patients with acute myeloyd leukemia. Leukemia Res 1990; 14: 227-240.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
11. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Villemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F. Molecular remission in the PML/RARa positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin AIDA therapy. Blood 1997; 90: 1014-1021.
12. Fasano ME, Praticò L, Brancatello F, Mazzola G, Cravero T, Bersanti M, Curtoni ES. Caucasian Italian normal. In: Terasaki P, Gjertson D (eds). HLA 1998. American Society for Histocompatibility and Immunogenetics: Lenexa, KS, 1999, p 162.
13. Francia di Celle P, Gay E, Marin F, Maderno P, Berrino M, Dall'Omo A, Curtoni ES. Caucasian Italian normal. In: Terasaki P, Gjertson D (eds). HLA 1998. American Society for Histocompatibility and Immunogenetics: Lenexa, KS, 1999, p 163.
14. Rendine S, Borelli I, Barbanti M, Sacchi N, Roggero S, Curtoni ES. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998; 52: 135-146.
15. Clayton J, Lonjou C. Allele and haplotype frequencies for HLA loci in various ethnic groups. In: D Charron (ed). Genetic Diversity of HLA. Functional and Medical Implication. EDK: Paris, 1997, 1: p 675.
16. Diverio D, Lo Coco F, D'Adamo F, Biondi A, Fagioli M, Grignani F, Rambaldi A, Rossi V, Avvisati G, Petti MC, Testi AM, Liso V, Specchia G, Fioritoni G, Recchia A, Frassoni F, Ciolli S, Pelicci PG for the Italian Cooperative Study group GIMEMA. Identification of DNA rearrangements at the retinoic acid receptor alfa RARa locus in all patients with acute promyelocytic leukemia APL and mapping of APL breakpoints within the RARa second intron. Blood 1992; 79: 3331-3336.
17. Diverio D, Riccioni R, Pistilli A, Buffolino S, Avvisati G, Mandelli F, Lo Coco F. Improved rapid detection of the PML/RARa fusion gene in acute promyelocytic leukemia. Leukemia 1996; 10: 1214-1216.
18. Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-158.
19. Tonks S, Marsh SGE, Bunce M, Moses JH, Krausa P, Sadler AM, Petronzelli F, Bodmer JG. HLA class I DNA typing study. In: D Charron (ed). Genetic Diversity of HLA. Functional and Medical Implication. EDK: Paris, 1997; 1: pp 188-193.
20. Oh S, Fleischhauer K, Yang SY. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens 1993; 41: 135-142.
21. Fleischhauer K, Zino E, Bordignon C, Benazzi E. Complete, generic and extensive fine-specificity typing of the HLA-B locus by the PCR-SSOP method. Tissue Antigens 1995; 46: 281-292.
22. Zino E, Severini GM, Mazzi B, Bordignon C, Benazzi E, Fleischhauer K. Sequencing of a new HLA-A*32 subtype A*3202. Immunogenetics 1996; 45: 76-77.
23. Grundschober C. Rufer N, Sanchez-Mazas A, Madrigal A, Jeannet M, Roosnek E, Tiercy JM. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles Cw*02023 and Cw*0707 and recognition by cytotoxic T lymphocytes. Tissue Antigens 1997; 49: 612-623.
24. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class supermotifs, Immunol today 1996; 17: 261-266.
25. Gambacorti-Passerini C, Bertazzoli C, Dermime S, Scardino A, Schendel D, Parmiani G. Mapping of HLA class I binding motifs in 44 fusion proteins involved in human cancers. Clin Cancer Res 1997; 3: 675-683.
26. Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 1995; 85: 2680-2684.
27. Bolognesi E, D'Alfonso S, Greco G, Tanigaki N, Fleischhauer C, Cimino G, Rapanotti C, Diverio D, Momigliano-Richiardi P. HLA class I and susceptibility to acute promyelocytic: leukemia, Eur J Immunogenet 1998; 25: S56.
28. Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 1998; 396: 373-376.